![Halo Collective Inc](/common/images/company/NEO_HALO.png)
Halozyme to Report Fourth Quarter and Full Year 2024 Financial and Operating Results PR Newswire SAN DIEGO, Feb. 4, 2025 SAN DIEGO, Feb. 4, 2025 /PRNewswire/ --ย Halozyme Therapeutics, Inc...
CHMP Issues Positive Opinion for Subcutaneous RYBREVANTยฎ(amivantamab) Co-Formulated with ENHANZEยฎ for the Treatment of Patients with Advanced EGFR-Mutated Non-Small Cell Lung Cancer PR...
Halozyme Reiterates 2024 Financial Guidance and Raises 2025 and Multi-Year Financial Guidance PR Newswire SAN DIEGO, Jan. 8, 2025 Reports Preliminary 2024 Unaudited Estimated Ranges Consistent...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | -5.23 | -99.619047619 | 5.25 | 5.75 | 0.015 | 1321000 | 0.43557418 | CS |
260 | -0.405 | -95.2941176471 | 0.425 | 35 | 0.015 | 2666733 | 0.36991871 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.